Lundbeck
HLUN-B.CO
#2789
Rank
NZ$7.87 B
Marketcap
$8.19
Share price
-1.37%
Change (1 day)
2.45%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.58

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.62. In 2022 the company made an earnings per share (EPS) of $0.47 a decrease over its 2021 EPS that were of $1.05.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5823.84%
2022$0.47-55.47%
2021$1.05-51.83%
2020$2.19-28.01%
2019$3.04-44.08%
2018$5.4451.94%
2017$3.58126.64%
2016$1.58-120.84%
2015-$7.575622.18%
2014-$0.13-110.03%
2013$1.32-28.08%
2012$1.83-52.1%
2011$3.83-1.31%
2010$3.8815.61%
2009$3.36